Neoleukin
Neoleukin Therapeutics develops and commercializes protein-based therapies for the treatment of cancer and immunological disorders.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Neoleukin Information
Neoleukin was acquired by
Aquinox Pharmaceuticals.
The acquisition happend on 2019-08-06.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 401 Terry Avenue North
City: Seattle
State: WA
Zip: 98109
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$71M
Raised Total:$158M
Social
Metrics
9,365,612Website Global Rank
169Website Monthly Traffic
Twitter Followers
Description
Neoleukin Therapeutics develops and commercializes protein-based therapies for the treatment of cancer and immunological disorders.
Contact Phone:
Contact Email:
Neoleukin went public on the NASDAQ
Listed Exchange:
NASDAQ
Ticker Symbol:
NLTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2018 | Venture Round | 1 | - |
Sahsen Ventures Sahsen Ventures |
7/2020 | Post-IPO Equity | $71.4M | 12/2019 | Post-IPO Equity | $86.2M | 1/2018 | Venture Round | 1 | - |
Sahsen Ventures Sahsen Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
